Table 2.
n (%) | |
---|---|
All Sex | 77 (100) |
male | 64 (83.1) |
female | 13 (16.9) |
Tumor site | |
Squamous cell carcinoma | 37 (48.1) |
adenocarcinoma | 39 (50.6) |
Neuroendocrine tumor | 1 (1.3) |
Neo-adjuvant treatment | |
yes | 32 (41.6) |
no | 45 (58.4) |
Adjuvant treatment | |
yes | 2 (2.5) |
no | 53 (68.8) |
unknown | 22 (28.6) |